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Abstract
AIM: The sphincter of Oddi (SO) plays an important role in
delivery of bile into the duodenum. To establish whether
vasoactive intestinal polypeptide (VIP) and nitric oxide (NO)
were involved in phasic contractile activity of the rabbit
SO stimulated by cholecystokinin-octapeptide (CCK-8).
METHODS: Isolated SO muscle rings were cleaned of fat
and mounted horizontally on two small L-shaped hooks
one of which was connected to a force transducer for the
measurement of isometric tension. The experiments were
carried out in a thermostatically controlled (37±0.2 )
organ bath (5 mL) containing Krebs solution. The organ
fluid was gassed with 95% O2 and 50 mL/L CO2 to keep
the pH at 7.40±0.05. Contractile responses to CCK-8
(1 µmol/L) were evaluated in the presence and absence
of NG-nitro-L-arginine (LNNA), an inhibitor of NO synthase
(100 µmol/L), and (p-chloro-D-Phe6-Leu17)-VIP (VIPa,
30 µmol/L), a VIP receptor antagonist.
RESULTS: CCK-8 stimulated the phasic activity of the SO.
NO synthase inhibition increased the frequency and amplitude
of contractions with a slight increase in developed tension.
Pre-incubation with VIPa also attenuated this CCK-8 effect.
The combined application of LNNA and VIPa abolished
the phasic activity of the muscle rings with a marked increase
in tension in response to CCK-8.
CONCLUSION: VIP and NO together contribute to an
increase in phasic activity of SO.
© 2005 The WJG Press and Elsevier Inc. All rights reserved.
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The sphincter of Oddi (SO) plays an important role in delivery
of bile into the duodenum. In animals like rabbits, opossums
and guinea pigs, the partially extraduodenal sphincter operates
like a peristaltic pump that actively squeezes bile into the
duodenum[1]. Thus, contraction and relaxation mechanisms
are of  equal importance in controlling normal sphincter
function. Regulation of the relaxation function of this
sphincter is mainly executed by non-adrenergic, non-cholinergic
(NANC) nerves[2]. With regard to the neurotransmitters involved,
evidence favors a role for vasoactive intestinal polypeptide
(VIP)[2] and nitric oxide (NO) in various species including guinea
pigs[3], rabbits[4], and humans[5]. In the rabbit SO the NANC
relaxation is completely blocked by NG-nitro-L-arginine methyl
ester (L-NAME), an inhibitor of NO-synthase[4]. The inhibitory
effect of L-NAME can be reversed by concurrent incubation
with L-arginine but not D-arginine indicating the response to
be essentially nitrergic. It is widely accepted that NO evokes
smooth muscle relaxation through formation of  cyclic GMP
within muscle cells[6]. Nevertheless, NO has been shown to
stimulate the release of  VIP from enteric nerve terminals, an
effect to enhance or contribute to its ‘per se’ relaxant effect[7].
Much less is known about the influence of endogenous
substances that promote the peristaltic pump-like sphincter
function through generating phasic contractions. Cholecystokinin
(CCK) is generally regarded as the major hormone regulating
postprandial SO motility. CCK has been shown to initiate
VIP and acetylcholine release at both pre- and post-junctional
sites in enteric nervous system through CCKA receptors,
whereas CCKB receptors seem to mediate NO release at post-
junctional sites[8]. Nevertheless, the contribution of NO and
VIP release to CCK-induced stimulation of phasic contractile
activity of the SO has not been explored. The present work
was therefore concerned with the possibility that an interplay
between NO and VIP would contribute a significant degree
to CCK-induced phasic contractions in the SO of  rabbits.
MATERIALS AND METHODS
Ethics
The experiments in the present work conformed to European
Guiding Principles for Care and Use of Experimental
Animals. In addition, the experimental protocol applied was
approved by the local ethical board of University of Szeged
and University of Debrecen, Hungary.
Isometric tension measurements
These measurements were described in detail elsewhere[4].
Biliary SO muscle rings of approximately 6 mm in length
from adult male New Zealand white rabbits weighing 3 500-
4 000 g were prepared. The papilla Vateri was eliminated
and the ampullary part of the muscle rings of approximately
3 mm in length were mounted horizontally on two small L-
shaped glass hooks of which one was connected to a force
transducer (SG-O2, Experimetria, Budapest, Hungary)
attached to a six channel polygraph (R61 6CH, Mikromed,
Budapest, Hungary) for measurement and recording of
isometric tension as described[4]. One muscle ring was prepared
from one animal. The experiments were carried out in an
organ bath (5 mL) containing Krebs bicarbonate buffer (mM:
NaCl 118.1, KCl 4.7, MgSO4 1.0, KH2PO4 1.0, CaCl2 2.5,
NaHCO3 25.0, glucose 11.1) which was maintained at
37  and aerated continuously with carbogen (50 mL/L CO2
in oxygen, Ph. Eur. III.). The initial tension was set at 10
mN and the rings were allowed to equilibrate for over an
hour. Cholecystokinin octapeptide (CCK-8, 0.01-10 µmol/L),
atropine (1 µmol/L), tertrodotoxin (TTX, 1 µmol/L), (p-
chloro-D-Phe6, Leu17)-VIP (VIPa, 30 µmol/L), and NG-
nitro-L-arginine (LNNA, 100 µmol/L) were added directly
to the organ bath in 50-150 µL volume.
Experimental protocol
The muscle rings underwent brief experimental protocols
as follows. Protocol 1: the preparations with a resting tension
of 10 mN were exposed to cholecystokinin-octapeptide
(CCK-8) (0.1 µmol/L, the EC50 for the peptide in this
preparation) subsequent to an equilibration period of over
60 min. After a stable contractile response was obtained,
the preparations were washed until tension returned to
previous baseline level. Protocols 2 and 3 were to study the
effect of atropine and TTX (1 µmol/L for both) on CCK-
8-induced increase in phasic activity. Atropine and TTX
were applied either prior to CCK-8 or at maximum increase
in phasic contractions, respectively. Protocols 4 and 5 were
to study the effect of NO synthase inhibition (100 µmol/L
LNNA) and neutralization of VIP action on CCK-8-induced
responses. The preparations were pre-incubated with either
100 µmol/L LNNA or 30 µmol/L VIPa for over 20 min,
and then CCK-8 (0.1 µmol/L) was given. In protocol 6,
LNNA and VIPa were applied together prior to CCK-8.
Except for protocol 3, baseline contractile patterns were
re-gained subsequent to washout; in case of TTX, however,
the decrease in baseline contractile amplitudes could not be
overcome even by extensive washout.
Drugs and chemicals
Atropine, TTX, LNNA, and CCK-8 were obtained from
Sigma Chemical Company (St. Louis, USA). Polyclonal VIPa
was a generous gift from Joseph Nemeth (Department
Pharmacology, Medical University of  Pecs). The compounds
were dissolved in Krebs solution and added directly to the
organ bath except for LNNA which was dissolved in ethanol
and then diluted with Krebs solution.
Data and statistical analysis
Parameters producing the data for evaluation were as follows.
The amplitude of contractions (mN) was referred to as the
difference between peak contractions and relaxations. The
averages of the amplitudes were calculated for every minute
(results are expressed as mean±SE, n = number of freque-
ncies in a minute). The frequencies of contractions (cpm) were
calculated for every minute. Statistical analysis was performed
for every 10 min of the experiments using either Student’s
t-test (when the data consisted of  two groups) or ANOVA
(when three or more data groups were compared). Results
were expressed as mean±SE, n = 5, P<0.05 was accepted
as statistically significant.
RESULTS
Effect CCK-8 on isolated SO motility
CCK (0.1 µmol/L) increased frequency and amplitude of
contractions, and elevated the developed tension of the
muscle rings (Figures 1A-C).
Effect of atropine and TTX on CCK8-stimulated SO contractions
CCK-8-stimulated SO contractions were blocked by TTX
(1 µmol/L). Atropine in the same concentration (1 µmol/L)
also abolished agonist-induced contractile activity.
Effect of LNNA and VIPa on CCK-8-stimulated SO motility
NO synthase inhibition by LNNA markedly increased the
frequency and amplitude of contractions with a slight increase
Figure 1  Effects of LNNA and VIPa on CCK-8-stimulated mechanical activity
of rabbit SO in vitro. A: Summary of the effect of  LNNA, VIPa and combined
application of these substances on CCK-8-induced change of tension. Data are
mean±SD, n = 6, aP<0.05 vs baseline. B: Summary of the effect of  LNNA, VIPa
and combined application of these substances on CCK-8-induced change of
amplitudes. Data are mean±SD, n = 6, aP<0.05 vs baseline. C: Summary of the
effect of  LNNA, VIPa and combined application of these substances on CCK-8-
stimulated contractile frequency. Data are mean±SD, n = 6, aP<0.05 vs baseline.
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in developed tension. Pre-incubation with polyclonal VIPa
attenuated each CCK-8 effect. Combined application of LNNA
and VIPa significantly increased the tension of CCK-8, but
abolished the phasic contractile activity of the muscle rings
(Figures 1A-C). Separate application of LNNA and VIPa
potentiated the effect of CCK-8-induced phasic contractions,
while combined application of these substances completely
abolished the phasic activity of the muscle rings with a marked
increase in tension in response to CCK-8. These results
indicated that VIP and NO together are mediators of the
CCK-8-stimulated phasic contractions in rabbit SO.
DISCUSSION
The results showed that the CCK-8-induced increase in phasic
contractile activity characterized by an amplification of
frequency of contractions superimposed on an increase in
tension was augmented by NO synthase inhibition. The
amplitude of contractions, exhibited only a tendency to
increase when the effect of CCK-8 on rings pre-exposed to
LNNA was studied.  Neutralization of VIP yielded an increase
in tension and a reduction of contractile amplitude with no
effect on frequency of contraction. NO synthase inhibition
together with neutralizing VIP completely blocked any phasic
activity after CCK-8 with a substantial increase in tension
i.e. this combined treatment converted the phasic activity
stimulating effect of CCK-8 to a pure increase in tonic
contraction.
As far as the mechanism of action of CCK on the SO is
concerned, previously it has been postulated that CCK at
least in the dog sphincter exerts the majority of its effect
through stimulation of receptors on smooth muscle cells[9].
Nevertheless, results by Behar and Biancani[10] revealed that
blockade of action potential propagation by TTX abolishes
the inhibitory effect of CCK on sphincter mechanics converting
its action to stimulation. This evokes the concept of the
involvement of neural inhibitory mechanisms in the CCK
effect that interact with stimulatory impulses targeted to
smooth muscle receptors. Regarding neural inhibition on
SO of rabbits, we have shown that it is primarily of nitrergic
origin[4]. NO besides producing smooth muscle relaxation
may enhance the release of VIP, which in turn may further
stimulate NO formation[7]. Moreover, CCK A receptors
have been found to stimulate VIP and acetylcholine release
from enteric nerve terminals at pre-and post-junctional sites,
whereas CCK B receptors seem to elicit NO release at post-
junctional sites[8]. The results that neither LNNA nor VIPa
was able to block the phasic activity stimulating effect of
CCK-8 but combined application of these substances resulted
in conversion of CCK-8 effects to a full contractile one
seem to support the assumption that an interplay between
VIP and NO is of crucial importance in the development
of phasic activity by CCK-8 in the rabbit SO. Moreover,
since both TTX and atropine could block the effect of
CCK-8, the majority of the effects of CCK-8 seem to be
mediated by cholinergic impulses.
To the best of  our knowledge this report is the first to
describe that the integrity of neural nitrergic and VIP-
mediated processes are pre-requisites for the ability of CCK-
8 to stimulate sphincter motility. Since in rapacious animals,
the peristaltic pump-like sphincter activity actively squeezes
bile into the duodenum, and this sphincter activity is underlain
by neurotransmitter release from either intrinsic or sensory
neurons, it is not surprising that diseases that deteriorate
these nerves impair sphincter function as well[11,12]. Of  course,
based on the present results it is not possible to estimate
whether or not the neural responses participate in CCK-8-
induced responses. However, that VIP and NO together
comprise the principle neural effectors of relaxation
interrupting tonic contractions evoked by CCK-8 in the
rabbit SO seem to be supported by the data obtained. Similarly,
the present work has not elucidated the precise role of
cholinergic impulses implicated in either contractile or
relaxant effects of CCK-8. Nevertheless, since similar to that
seen with TTX, atropine also blocked the CCK-8 effects,
thus it is possible that cholinergic nerves besides eliciting
contractions may facilitate relaxation through releasing NO
or VIP or other currently undefined relaxants.
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